It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy, recently classified in small duct and large duct morphological subtypes. Growing evidence suggests asbestos as a putative risk factor for iCCA, albeit no correlation between asbestos and iCCA morphology has been investigated so far. The aim of the present study was to assess the relationship between asbestos exposure and iCCA morphological subtype. Forty patients with surgically removed iCCA were prospectively enrolled: asbestos exposure was assessed according to the Italian National Mesothelioma Register questionnaire. From the surgical iCCA specimens the main histopathological variables were collected, including the small duct (sd-iCCA, 32 patients) and large duct subtypes (ld-iCCA, 8 patients). Five sd-iCCA cases had a definite/probable occupational exposure to asbestos, while no cases of ld-iCCA were classified as being occupationally exposed (definite/probable). Other kind of asbestos exposure (i.e. possible occupational, familial, environmental) were recorded in 16 sd-iCCA and 3 ld-iCCA. Cases with unlikely exposure to asbestos were 11 sd-iCCA (35.5%) and 5 ld-iCCA (62.5%). In conclusion, these findings seem to indicate that sd-iCCA might be more frequently associated to asbestos exposure rather than ld-iCCA, suggesting that asbestos fibres might represent a parenchymal, rather than a ductal risk factor for iCCA. This pilot study must be confirmed by further case–control studies or large independent cohorts.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Pathology Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
2 University of Bologna, Department of Specialty, Diagnostic and Experimental Medicine, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758); IRCCS Azienda Ospedaliero-Universitaria di Bologna, Oncology Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
3 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Oncology Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
4 University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
5 University of Ferrara, Department of Environmental and Prevention Sciences, Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064)
6 IRCCS Azienda Ospedaliero-Universitaria di Bologna, General and Transplant Surgery Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)